Market Cap 231.80M
Revenue (ttm) 0.00
Net Income (ttm) -55.85M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.24
Volume 2,539,400
Avg Vol 1,106,612
Day's Range N/A - N/A
Shares Out 59.90M
Stochastic %K 85%
Beta 0.68
Analysts Strong Sell
Price Target $9.00

Company Profile

Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP) modulator, which is in Phase III clinical trial for the treatment of dry eye disease and allergic conjunctivitis; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment retinitis pigmentosa. The company also develops ADX-629, an orally administered RASP modulator th...

Industry: Biotechnology
Sector: Healthcare
Phone: 781 761 4904
Fax: 339 674 6495
Address:
131 Hartwell Avenue, Suite 320, Lexington, United States
jaymar19
jaymar19 Jun. 28 at 8:08 AM
$ALDX REPROXALAP TO THE MOON 🌕 🚀😉
0 · Reply
jaymar19
jaymar19 Jun. 28 at 8:07 AM
$ALDX I want to say one thing, I may not use the best choice of language to display my intent . But when I post , I post with the intent to help and provide an opinion for those who lack the depth of understanding of this stock, company, and medicine . And in the general the biotech industry . Again, take it or leave it. Listen or tune me out. When I was a rookie, all I wanted was someone who would tell me a real honest “experienced” opinion. No some bs false hope, or some bs trolling garbage. I’ll never tell you how to play or what games to play… but I’ll always give my 2 cents to assist you in any decision making you are working on.
1 · Reply
jaymar19
jaymar19 Jun. 28 at 7:32 AM
$ALDX I ruffled some feathers with my last post… It’s my 2 cents . Take it or leave it 🤷🏼‍♂️ But to comment off the excitement of the FDA SPA for ADX-2191… First I will say it is good news…. But I’m afraid most here are a little naive to how Biotech works. Especially a medicinal driven company. The SPA trail will begin some point in the 2H of 2025. (Wonderful) but data won’t be set to review until 2026 . (My guess Q1 maybe Q2 2026) so still far away. (I said you won’t see double digits for another year-ish) And this SPA, if given approval doesn’t move the marker much. It’s NDA approval or bust. The SPA is just a piece to developing a NDA worthy of approval. If the SPA gets approved I don’t expect anything greater than a 100% increase (current PP) . Sure maybe you see 8$-9$ . An NDA approval which gains much stronger odds for approval with a successful NDA is where the double digits will be guaranteed. If SPA goes well and all endpoints are met an NDA review won’t be until Q4+
1 · Reply
MontanaT
MontanaT Jun. 28 at 6:51 AM
$ALDX amazing week we had. have a good weekend everyone! 🦍🦍🦍
0 · Reply
GoldmanSlaps
GoldmanSlaps Jun. 27 at 9:26 PM
$ALDX is that you perceptive? 😆
3 · Reply
Greene2
Greene2 Jun. 27 at 9:16 PM
$ALDX I hate how Nasdaq changed their website. 662k shares traded after hours and I can’t tell if one share or 600 thousand shares went for $3.85.
0 · Reply
All4Retiring
All4Retiring Jun. 27 at 8:17 PM
$ALDX Have a wonderful weekend everyone.
0 · Reply
oochiegoochie
oochiegoochie Jun. 27 at 8:13 PM
$ALDX healthy
0 · Reply
ThePorscheGuy
ThePorscheGuy Jun. 27 at 6:18 PM
$ALDX what a selloff
1 · Reply
RoyBasch
RoyBasch Jun. 27 at 5:11 PM
$ALDX I don’t care if the stock is at $3, $4, or $5 right now. I care whether it hits $30, $40, or even $50+ down the line. If you truly believe Reproxalap will be approved – and you see the strength of the pipeline behind it – then the current price is just noise. Reproxalap’s approval will be the moment everything changes.
1 · Reply
Latest News on ALDX
Aldeyra Therapeutics Appoints Chip Clark to Board of Directors

Apr 17, 2025, 7:00 AM EDT - 2 months ago

Aldeyra Therapeutics Appoints Chip Clark to Board of Directors


jaymar19
jaymar19 Jun. 28 at 8:08 AM
$ALDX REPROXALAP TO THE MOON 🌕 🚀😉
0 · Reply
jaymar19
jaymar19 Jun. 28 at 8:07 AM
$ALDX I want to say one thing, I may not use the best choice of language to display my intent . But when I post , I post with the intent to help and provide an opinion for those who lack the depth of understanding of this stock, company, and medicine . And in the general the biotech industry . Again, take it or leave it. Listen or tune me out. When I was a rookie, all I wanted was someone who would tell me a real honest “experienced” opinion. No some bs false hope, or some bs trolling garbage. I’ll never tell you how to play or what games to play… but I’ll always give my 2 cents to assist you in any decision making you are working on.
1 · Reply
jaymar19
jaymar19 Jun. 28 at 7:32 AM
$ALDX I ruffled some feathers with my last post… It’s my 2 cents . Take it or leave it 🤷🏼‍♂️ But to comment off the excitement of the FDA SPA for ADX-2191… First I will say it is good news…. But I’m afraid most here are a little naive to how Biotech works. Especially a medicinal driven company. The SPA trail will begin some point in the 2H of 2025. (Wonderful) but data won’t be set to review until 2026 . (My guess Q1 maybe Q2 2026) so still far away. (I said you won’t see double digits for another year-ish) And this SPA, if given approval doesn’t move the marker much. It’s NDA approval or bust. The SPA is just a piece to developing a NDA worthy of approval. If the SPA gets approved I don’t expect anything greater than a 100% increase (current PP) . Sure maybe you see 8$-9$ . An NDA approval which gains much stronger odds for approval with a successful NDA is where the double digits will be guaranteed. If SPA goes well and all endpoints are met an NDA review won’t be until Q4+
1 · Reply
MontanaT
MontanaT Jun. 28 at 6:51 AM
$ALDX amazing week we had. have a good weekend everyone! 🦍🦍🦍
0 · Reply
GoldmanSlaps
GoldmanSlaps Jun. 27 at 9:26 PM
$ALDX is that you perceptive? 😆
3 · Reply
Greene2
Greene2 Jun. 27 at 9:16 PM
$ALDX I hate how Nasdaq changed their website. 662k shares traded after hours and I can’t tell if one share or 600 thousand shares went for $3.85.
0 · Reply
All4Retiring
All4Retiring Jun. 27 at 8:17 PM
$ALDX Have a wonderful weekend everyone.
0 · Reply
oochiegoochie
oochiegoochie Jun. 27 at 8:13 PM
$ALDX healthy
0 · Reply
ThePorscheGuy
ThePorscheGuy Jun. 27 at 6:18 PM
$ALDX what a selloff
1 · Reply
RoyBasch
RoyBasch Jun. 27 at 5:11 PM
$ALDX I don’t care if the stock is at $3, $4, or $5 right now. I care whether it hits $30, $40, or even $50+ down the line. If you truly believe Reproxalap will be approved – and you see the strength of the pipeline behind it – then the current price is just noise. Reproxalap’s approval will be the moment everything changes.
1 · Reply
brickross
brickross Jun. 27 at 5:10 PM
$ALDX Waiting on Montana to post his positions still after he bragged about his crystal ball working during yesterday's run around non Reproxalap news. Guy isn't trading on technicals. Definitely isn't trading on actual knowledge of the market or science. TODd wILL tAKE uS HoME is his only rally cry.
1 · Reply
MontanaT
MontanaT Jun. 27 at 4:10 PM
0 · Reply
Milanfinest
Milanfinest Jun. 27 at 3:58 PM
$ALDX can we skip the part where it bounce on the support at 2.70 etc and we directly go to 10$?
0 · Reply
Aidsg
Aidsg Jun. 27 at 1:50 PM
$ALDX starting to see large volume earlier in the days, it's getting crowded in here!
0 · Reply
GoldmanSlaps
GoldmanSlaps Jun. 27 at 1:46 PM
$ALDX some massive buying today very unusual
0 · Reply
Nikata_G
Nikata_G Jun. 27 at 1:16 PM
$ALDX just imagine how easy is for insiders to dump before the CRL and load right after that at 1.40ish… smh…
0 · Reply
silentmaxx
silentmaxx Jun. 27 at 1:08 PM
0 · Reply
AllinDeyra
AllinDeyra Jun. 27 at 1:02 PM
$ALDX all is possile now... 5, 7, 9,12, 15...
0 · Reply
AllinDeyra
AllinDeyra Jun. 27 at 1:01 PM
$ALDX 4 usd We are back
0 · Reply
FATSTAX
FATSTAX Jun. 27 at 11:56 AM
$SPY $QQQ $ALDX Weekly Pros = white candles 200 ema = aqua line 9 consecutive prior pro highs cleared over the $3.77 12/28/23 high is a 200 ema retest threat.
0 · Reply
Milanfinest
Milanfinest Jun. 27 at 11:21 AM
0 · Reply
All4Retiring
All4Retiring Jun. 27 at 9:44 AM
$ALDX There is some great potential in the pipeline. More than just a Reproxalap company.
0 · Reply